NCT01552304View on ClinicalTrials.gov

Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients

NACompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Obstructive Sleep Apnea
Interventions
OTHER

Oxygen therapy

Besides perioperative routine care provided by anesthesiologists and surgeons, patients will receive postoperative oxygen supplementation with nasal prolong at 3 liters/min during the first 3 nights after surgery.

OTHER

Control group

Trial Locations (1)

M5T2S8

Toronto Western Hospital, Department of Aneshtesia, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01552304 - Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients | Biotech Hunter | Biotech Hunter